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AbstrACt
Introduction Although Rwanda’s health system 
underwent major reforms and improvements after the 
1994 Genocide, the health system and population health in 
the southeast lagged behind other areas. In 2005, Partners 
In Health and the Rwandan Ministry of Health began a 
health system strengthening intervention in this region. We 
evaluate potential impacts of the intervention on maternal 
and child health indicators.
Methods Combining results from the 2005 and 2010 
Demographic and Health Surveys with those from a 
supplemental 2010 survey, we compared changes in 
health system output indicators and population health 
outcomes between 2005 and 2010 as reported by women 
living in the intervention area with those reported by the 
pooled population of women from all other rural areas 
of the country, controlling for potential confounding by 
economic and demographic variables.
results Overall health system coverage improved 
similarly in the comparison groups between 2005 and 
2010, with an indicator of composite coverage of child 
health interventions increasing from 57.9% to 75.0% in 
the intervention area and from 58.7% to 73.8% in the 
other rural areas. Under-five mortality declined by an 
annual rate of 12.8% in the intervention area, from 229.8 
to 83.2 deaths per 1000 live births, and by 8.9% in other 
rural areas, from 157.7 to 75.8 deaths per 1000 live births. 
Improvements were most marked among the poorest 
households.
Conclusion We observed dramatic improvements in 
population health outcomes including under-five mortality 
between 2005 and 2010 in rural Rwanda generally and in 
the intervention area specifically.
IntroduCtIon
The 1994 Rwanda Genocide was followed 
by a profound decline in population health 
that persisted for almost a decade. In the 
aftermath of the killing of nearly 20% of the 
population, HIV incidence soared, a cholera 
Key questions
What is already known?
 ► Much of the evidence that health system 
strengthening in rural Africa has improved health 
outcomes comes from studies of targeted regional 
interventions such as performance-based financing 
or community health worker programmes, rather 
than integrated interventions that encompass 
multiple components including infrastructure and 
supply chain investments, health management 
information system, workforce training and 
incentives at all levels, community health  
workers and free services for poor  
patients.
 ► In addition to these experimental or 
quasiexperimental studies, a series of case studies 
have documented individual nations’ Pathways to 
Achieving Millennium Development Goal 4 target, 
the reduction of under-five mortality by two-thirds 
between 1990 and 2015.
 ► These reports suggest that improvements in 
coverage of reproductive, maternal and child health 
indicators explain some, but not all, of the decline in 
child mortality and that these successes occurred 
in the context of national gains in health, nutrition 
and food security, sanitation, poverty reduction and 
access to clean water.
What are the new findings?
 ► Coverage of most maternal and child healthcare 
interventions improved at a similar pace in our rural 
intervention area and other rural areas.
 ► Despite experiencing poorer health outcomes in 
2005, our rural intervention area caught up to or 
exceeded other rural areas on 23 of 25 population 
health indicators by 2010.
 ► Infant and under-five mortality declined in our rural 
intervention area even more precipitously than in 
other rural areas of Rwanda between 2005 and 
2010.
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epidemic among the Rwandan refugees ensued and 
vaccination rates plummeted. In 2000, the new govern-
ment launched a development initiative, Vision 2020, 
of which health equity was a major component, and in 
2003, Rwanda established health as an inalienable right.1 
The many healthcare initiatives implemented nation-
ally between 2003 and 2010 included a national health 
insurance policy,2 performance-based financing of 
health programmes,3 a village community health worker 
programme,3 scale up of vaccinations,4 HIV treatment5 
and malaria reduction initiatives.6 Between 2004 and 
2011, antiretroviral therapy coverage increased sevenfold 
to 94%, and by 2011,7 the government of Rwanda spent 
10% of public expenditure on health.8 
In 2005, the non-governmental organisation, Partners 
In Health (PIH), and the Rwandan Ministry of Health 
(RMOH) began a collaboration to strengthen the health 
system in a region of southeastern Rwanda (hence-
forth referred to as Kirehe/S. Kayonza) where health 
outcomes were among the worst in Rwanda. Children in 
this area experienced higher rates of death, acute respi-
ratory infection (ARI), diarrhoea and fever than in the 
other rural areas (ORAs) of the country.9 To address this, 
PIH and RMOH jointly led a regional effort based on the 
World Health Organization six building blocks of health 
system strengthening.10
The intervention included the renovation and equip-
ping of dysfunctional health facilities, the recruitment, 
retention and training of a health workforce, the devel-
opment of a medical record system, the procurement of 
medical products and technologies, financial support 
to offset health insurance premium costs and user fees 
and the development of governance strategies to ensure 
the longevity of the project. These interventions coin-
cided with major RMOH reforms to coordinate external 
aid with government policies, scale-up a communi-
ty-based health insurance scheme and introduce perfor-
mance-based pay into the district health system.11 
Notably, many of these interventions were designed to 
reduce child mortality rates by increasing the coverage of 
preventative measures such as vaccination and antenatal 
visits and through the expansion of community health 
worker networks and provision of high-quality medical 
care at primary, secondary and tertiary health facilities. 
The intervention included an accompagnateur community 
health worker role not present in the rest of the country 
to provide patients with HIV/AIDS, tuberculosis and 
other chronic conditions with daily home visits. Specific 
aspects of the RMOH-PIH intervention are described in 
the online supplement and reviewed elsewhere.12
An important principle of the RMOH-PIH collabo-
ration in Kirehe/S. Kayonza was to leverage existing 
resources rather than spend limited resources on 
building new systems. Routinely conducted Demographic 
and Health Surveys (DHSs) provide extensive data that 
can be used to measure health system outputs and popu-
lation health outcomes.13 Here, we assessed the impact 
of the RMOH-PIH intervention using data from two 
DHSs sequentially conducted in Rwanda 5 years apart.
MetHods
We evaluated the impact of the RMOH-PIH interventions 
by comparing the temporal trends in health outputs and 
outcomes between 2005 and 2010 in the intervention 
target region to those in the pooled population of all 
ORAs. First, we assessed health system outputs, focusing 
on a set of indicators meant to capture the coverage of 
maternal and child health services and then we assessed 
population outcomes including neonatal, infant and 
under-five mortality.
data
We used Rwanda Demographic and Health Survey 
(RDHS) data collected from 21 338 women living in 
Kirehe/S. Kayonza (K/SK) and ORAs in 2005 (K/SK: 
418, ORA: 8217) and 2010 (K/SK: 2073, ORA: 10 630) 
(table 1). RDHSs are nationally and subnationally repre-
sentative two-stage cluster samples conducted roughly 
every 5 years by the RMOH, National Institute of Statis-
tics-Rwanda (NISR) and ICF International. The surveys 
collect information from women aged 15–49 on their 
reproductive health histories, practices and desires; house-
hold composition; siblings’ survival; and children’s health 
and survival. The DHS birth history module included the 
date of the birth and death of each child born alive, and 
through the sibling module, the age and date of death 
for each biological sibling (see online supplement). The 
2005 RDHS was underway at the onset of the RMOH-PIH 
collaboration. In order to expand the sample size to 
allow us to compare the intervention area to other areas, 
we coordinated with the NISR immediately following the 
2010 RDHS to collect a supplemental sample of 1391 
households from 54 primary sampling units (PSUs) in 
Kirehe/S. Kayonza using the same sampling frame, staff 
and questionnaires as the 2010 RDHS (figure 1).12 Most 
data were collected consistently across the three surveys 
Key questions
What do the new findings imply?
 ► The process of strengthening national health systems often 
involves trade-offs between a focus on first testing individual 
programmes that distributed widely, as is often practised by 
pilot programmes with multilateral institutions, or implementing 
multiple simultaneous programmes locally. Our results show 
that integrated health system strengthening interventions can 
be locally adapted to enable the rapid expansion of healthcare 
coverage as well as dramatic improvements in population health 
outcomes.
 ► Integrated multilevel interventions can also help narrow the 
healthcare coverage and outcome gap between richer and poorer 
members of a society.
 ► National governments can leverage non-governmental partners to 
achieve the health-related sustainable development goals through 
joint implementation of national health policy.
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(2005 RDHS, 2010 RDHS and Supplemental RDHS) 
although neither stunting and wasting was assessed in 
the supplemental survey. The response rates for surveyed 
women were 98% in 2005 and 99% in 2010. The RDHS 
urban/rural boundaries were adopted from the Rwandan 
government. Exact urban boundaries are not published, 
however, urban areas are described as being built up, 
population dense and having public services and facili-
ties. All areas not meeting this definition are considered 
rural.14
Indicators
We assessed the following child health-related health 
system output indicators: whether treatment was provided 
for recent episodes of ARI, diarrhoea or fever in children 
under age 5 years; whether children under age 2 years 
received the recommended three doses of diphthe-
ria-polio-tetanus (DPT) or measles vaccine; whether chil-
dren received vitamin A supplementation between age 
6 months and 1 year; whether children were exclusively 
breastfed for the first 6 months of life; whether at least 
one, or the recommended four, antenatal care visits 
took place during the last pregnancy; whether the most 
recent birth was attended by a skilled health worker; 
whether the birth was delivered by caesarean section; 
whether women received postnatal care within 24 hours 
of delivery; women’s current contraceptive use; and their 
unmet need for contraception. The following population 
health outcome indicators were assessed: neonatal, infant 
and under-five mortality; adult mortality (men, women 
and combined); recent occurrence of ARI, diarrhoea or 
fever in children under age 5 years; and stunting and 
wasting in children under age 5 years.15
We calculated a composite coverage index (CCI) for 
both groups to monitor overall healthcare coverage 
across time in the intervention and comparison areas 
based on that proposed by Barros and Victoria (2013) 
but modified to exclude BCG tuberculosis vaccination 
coverage (which was not available) as an indicator.16 
Table 1 Summary of sociodemographic characteristics in 2005 and 2010
2005 2010 Comparison of group trends
ORA K/SK ORA K/SK P values*
Women (15–49 years)
  Age 28.6 28.1 28.6 28.7 0.059
  Married/partnered (%) 50.6 54.1 51.2 54.4 0.904
  Employed (%) 94.6 94.6 86.1 87.9 0.379
  Literacy (%) 68.0 63.7 75.2 73.3 0.454
N (weighted) 8877 523 10 957 2084
N (unweighted) 8217 418 10 630 2073
Households
  Wealth score† −0.246 −0.290 0.242 0.293 0.013
  Electricity (%) 1.4 <0.1 4.1 4.5 0.175
  Finished floor (%) 7.1 5.1 10.7 8.5 0.902
  Improved water (%) 27.9 47.5 72.4 65.5 0.014
  Members 15+ with primary 
education (%) 66.7 70.5 75.2 75.2 0.205
N (weighted) 8168 498 10 157 2041
N (unweighted) 7702 394 9891 2031
Primary sampling units
  Distance to road (metres) 3105 3275 3221 2960 0.543
  Distance to Kigali (km) 50.8 49.6 47.2 46.3 0.972
  Elevation (metres) 1763 1488 1800 1527 0.990
  January average rainfall (mm) 113 117 113 115 0.483
  April average rainfall (mm) 175 176 175 176 0.965
  July average rainfall (mm) 83 67 83 69 0.507
  October average rainfall (mm) 188 179 188 180 0.417
N (unweighted) 331 17 388 79
*Based on t-test from an OLS regression with year, group and year–group interaction terms.
†With respect to 2005 wealth score definition.
K/SK, Kirehe/S. Kayonza; OLS, ordinary least squares; ORA, other rural area.
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The modified CCI is a weighted average for a group that 
includes the prevalence of met need for contraception 
(FPS), skilled birth attendance (SBA), at least one ANC 
visit with a skilled provider (ANCS), third DTP vaccina-
tion (DPT3), measles vaccination (MSL), oral rehydra-
tion therapy (ORT) for children with diarrhoea and care 
seeking for pneumonia symptoms (CPNM) as follows:
 
 
mCCI = 14
(
FPS + SBA+ANCS2 +
2
(
DPT3
)
+MSL
3 +
ORT+CPNM
2
)
 
 
Analysis
We integrated the data from the supplemental survey 
with that from the 2010 RDHS as follows. Sampling 
probability weights were recalculated for the combined 
2010 dataset. To protect respondent confidentiality, we 
randomly geodisplaced PSU latitude/longitude coor-
dinates in the supplemental survey up to 5 km within 
district boundaries according to DHS guidelines.17 All 
geographic information was linked to displaced PSU loca-
tions in a geographic information system (ArcGIS V.10, 
ESRI). We combined latitude/longitude coordinates 
and rural residence information to identify respondents 
living in Kirehe/S. Kayzona and ORAs. Additional PSU 
geographic characteristics included straight-line distance 
to the nearest main road in metres (downloaded from 
DIVA-GIS database), straight-line distance to Kigali prov-
ince in kilometres (downloaded from Map Library data-
base), elevation above sea level in metres (from RDHS) 
and 30-year (1971–2000) average total rainfall in milli-
metres during the months of January, April, July and 
October (downloaded from US National Oceanic and 
Atmospheric Administration Climate Prediction Center). 
We generated comparable household wealth scores for 
2010 using the principle components generated from 
the 2005 RDHS,18 and we considered a household to be 
‘poor’ if it ranked in the bottom 20% of wealth scores of 
the pooled 2005, 2010 and supplemental survey datasets. 
Three rural PSUs (representing 69 households and 70 
women) were excluded from the 2005 dataset because 
the PSU GPS coordinate was missing, preventing the PSU 
from being linked to either Kirehe/S. Kayonza or ORA.
We compared baseline differences in woman, house-
hold and community (PSU) characteristics between the 
two comparison groups using χ2 tests and t-tests and 
temporal changes in and between groups using ordinary 
least squares regression with a year, group and year-by-
group interaction term. Since the intervention area and 
ORAs may differ by factors that would have an impact 
on child mortality but which would not be altered by 
our health system strengthening intervention, we also 
compared the following social and geographic character-
istics of sampled communities: fraction of each PSU with 
improved water, fraction of PSU adults who received a 
primary education, distance of PSU to a main road and 
to Kigali, elevation and average total rainfall in specified 
months. Finally, we compared health system outputs and 
population health measures at baseline.
Kirehe/S. Kayonza had been chosen as the site of the 
intervention, because it had the highest rate of under-
five mortality in Rwanda in 2005; thus, it was not possible 
to identify another Rwandan rural site with comparable 
under-five mortality. In an attempt to identify an optimal 
comparison group for Kirehe/S. Kayonza, we first limited 
our comparison area to Eastern Province in proximity 
to the intervention area (see figure 1). We found under-
five mortality was higher in the intervention area than 
the rest of Eastern Province or any other subregion, 
and comparisons of other indicators were mixed (see 
Figure 1 Maps of RDHS strata and primary sampling units in 2005 (left) and 2010 (right) and the PIH-RMOH intervention area 
in southeastern Rwanda (green). PIH, Partners In Health; RDHS, Rwanda Demographic and Health Survey; RMOH, Rwandan 
Ministry of Health.
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online supplement). When a subregion was not identified 
for comparison, we used propensity score matching with 
inverse probability of treatment weights to identify compa-
rable communities from ORAs by assessing PSU charac-
teristics that might differ between the intervention and 
comparison areas but which would not be expected to be 
altered by the intervention (distance to road, distance to 
Kigali, elevation and average rainfall). We generated a bias 
B value to capture the difference in the standard deviation 
between the means of the groups and an R value that is 
the ratio of variances in the two groups. Following Rubin, 
we considered the groups to be balanced if B was less than 
25% and R was between 0.5 and 2.19 Kirehe/S. Kayonza 
and ORAs were balanced by the R value but not by the 
B bias value (B=340.9, R=0.54) (see online supplement). 
Since neither approach identified a more appropriate 
comparison group, we compared Kirehe/S. Kayonza to all 
ORAs adjusting models for sociodemographic character-
istics that followed different trends in Kirehe/S. Kayonza 
and ORAs over time.
We used ordinary least squares regression with group, 
year and group–year interaction terms to model changes 
in binary health outputs and outcomes, controlling for 
differences in woman’s age and household wealth. We 
modelled change in childhood mortality rates using the 
DHS synthetic life-table approach, which uses the histories 
of all children a mother reports to have been alive during 
the previous 5 years.20 Adult mortality rates were based on 
a 5-year synthetic cohort of respondent’s siblings' births 
and deaths.21 Expected mortality rates were calculated 
by standardising mortality rates of ORAs to the age struc-
ture in Kirehe/S. Kayonza. We estimated mean changes 
between 2005 and 2010 as the absolute difference in rates, 
and we calculated variances of trends as the sum of year–
group variances. We adjusted for clustering of observa-
tions by PSU using Taylor linearised variance estimation 
in regression models and jackknife repeated replications 
to estimate variance in all other analyses.21 We conducted 
regressions in Stata V.13 and mortality analyses in SAS 
V.9.2.
ethics statement
Verbal consent was obtained for all respondents before 
interviews took place. Protocols for the Rwanda 2005 
and 2010 DHSs were approved by the Rwandan govern-
ment. Protocols for the 2010 supplemental survey were 
reviewed and approved by the Partners HealthCare 
Internal Review Board (protocol #: 2009 P-001941/8) 
and the Rwanda National Ethics Committee. 
role of the funding source
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results
demographic and geographical data
At baseline, women in Kirehe/S. Kayonza and ORAs were 
similar in terms of age, marital status, employment and 
literacy. Households in Kirehe/S. Kayonza had fewer 
household assets but greater access to improved water 
sources than in ORAs (table 1). Kirehe/S. Kayonza also 
differs from ORAs in terms of its geography; this region 
has lower elevation and lower rainfall during the second 
half of the calendar year (table 1). Between 2005 and 
2010, households in Kirehe/S. Kayonza acquired more 
assets than in ORAs and the age distribution of women 
shifted to the right. Access to improved water sources 
rose more steeply in the ORAs during the study period 
(table 1).
Health system outputs
Table 2 shows that after we adjusted for household wealth 
and woman’s age, baseline health system outputs were 
not significantly different in Kirehe/S. Kayonza with 
some exceptions: vitamin A supplementation was lower 
in Kirehe/S. Kayonza than in the ORAs (72.3% vs 84.3%, 
P=0.005), while contraception use among married 
women was higher (13.9% vs 8.2%, P=0.011) in Kirehe/S. 
Kayonza than in the ORAs (table 2, column D).
Most health system output indicators improved signifi-
cantly between 2005 and 2010 in both groups (table 2, 
column H), although for many indicators, the compar-
ison of trends between the two groups were not statisti-
cally significant (table 2, column I). Indicators that did 
not improve over time included exclusive breast feeding 
for the first 6 months of life and treatment of fever which 
did not change significantly in either group between 
2005 and 2010 (table 2, column H). The proportion of 
children treated for ARI rose from 18.7% to 54.6% in 
Kirehe/S. Kayonza and from 26.2% to 36.5% in ORAs 
(P=0.001), while proportion of women receiving four 
antenatal visits rose from 10.4% to 26.9% in Kirehe/S. 
Kayonza and from 12.8% to 35.2% in ORAs (P=0.057) 
(table 2, column I). Overall health system coverage as 
measured by the modified CCI increased from 57.9% to 
75.0% in Kirehe/S. Kayonza and from 58.7% to 73.8% in 
ORAs (table 2).
Population health outcomes
After adjustment, we found that most baseline measures 
of child health were worse in Kirehe/S. Kayonza than 
in ORAs (10.99% more ARI, P=0.005; 5.41% more diar-
rhoea, P=0.038; 11.91% more fever, P=0.003; 72 more 
under-five deaths per 1000 births, P=0.045), with the 
exception of stunting, which was 5.43% more preva-
lent in ORAs (P=0.018) (table 3, column D). We noted 
improvements between 2005 and 2010 for both groups 
in ARI, fever, neonatal mortality, infant mortality and 
under-five mortality (P<0.05 for all) (table 3, column H); 
these improvements were greater for ARI, diarrhoea, 
and fever in Kirehe/S. Kayonza (P<0.05 for all) (table 3, 
column J).
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Table 2 Health system outputs 2005–2010 in Kirehe/S. Kayonza (K/SK) and other rural areas (ORAs)
Indicator 
(subpopulation)
A
2005 2010 Trends
Comparison of 
trends
B C D E F G H I
Region N % (95% CI)
K/SK versus 
ORA (P values) N % (95% CI)
K/SK versus 
ORA (P values)
2005 versus 2010 
(P values)
2005–2010 K/SK 
versus ORA (P 
values)
Children
Exclusively 
breastfed by 
mother
(last born 
0–5 months)†
K/SK 35 89.50 
(76.26 to 102.73)
0.29 (0.966) 130 92.12
(87.09 to 97.29)
5.63 (0.066) 2.07 (0.775) 5.34 (0.478)
ORA 735 89.21 
(86.53 to 91.88)
583 86.56 
(83.40 to 89.71)
−3.27 (0.131)
Received third 
DPT vaccine
(12–23 months)† 
K/SK 68 91.41 
(85.17 to 97.65)
4.05 (0.236) 252 97.16 
(95.07 to 99.24)
0.06 (0.960) 5.45 (0.106) −3.99 (0.270)
ORA 1344 87.36 
(84.93 to 89.80)
1366 97.10 
(96.05 to 98.14)
9.44 (<0.001)
Received measles 
vaccine
(12–23 months)†
K/SK 68 73.91 
(61.53 to 86.29)
−11.79 (0.071) 252 92.08 
(88.36 to 95.80)
−2.95 (0.144) 17.76 (0.007) 8.74 (0.198)
ORA 1344 85.59 
(82.78 to 88.41)
1366 95.03 
(93.66 to 96.40)
9.02 (<0.001)
Vitamin A 
supplement in 
last 6 months 
(6–59 months)†
K/SK 330 77.27 
(72.74 to 81.80)
−7.04 (0.005) 1272 89.14 
(86.48 to 91.79)
−3.93 (0.006) 11.70 (<0.001) 3.11 (0.280)
ORA 5549 84.31 
(82.43 to 86.20)
6556 93.07 
(92.15 to 93.99)
8.59 (<0.001)
ARI in last 
2 weeks and 
received treatment 
(<5 years)†
K/SK 100 18.69 
(9.93 to 27.45)
−7.51 (0.115) 116 54.58 
(43.47 to 65.69)
18.05 (0.003) 34.53 (<0.001) 25.56 (0.001)
ORA 1022 26.19 
(22.98 to 29.40)
720 36.53 
(32.58 to 40.48)
8.97 (0.001)
Diarrhoea in last 
2 weeks and 
received ORT 
(<5 years)†
K/SK 72 12.12 
(0.82 to 23.42)
−5.62 (0.346) 169 34.58 
(26.46 to 42.70)
0.64 (0.887) 21.22 (0.003) 6.26 (0.402)
ORA 886 17.74 
(14.76 to 20.72)
931 33.94 
(30.52 to 37.37)
14.97 (<0.001)
Fever last 2 weeks 
and received 
(<5 years)†
K/SK 138 18.77 
(9.95 to 27.59)
6.74 (0.146) 215 11.41 
(6.68 to 16.13)
0.55 (0.838) −7.38 (0.150) −6.19 (0.248)
ORA 1619 12.03 
(9.82 to 14.25)
1140 10.86 
(8.50 to 13.22)
−1.19 (0.484)
Women
1+ antenatal care 
visit
(births last 
5 years)†
K/SK 277 96.77 
(95.03 to 98.51)
2.14 (0.035) 1058 98.37 
(97.54 to 99.21)
0.39 (0.420) 1.45 (0.142) −1.75 (0.117)
ORA 4374 94.63 
(93.66 to 95.60)
5255 97.99 
(97.56 to 98.42)
3.20 (<0.001)
4+ antenatal care 
visit
(births last 
5 years)†
K/SK 277 10.35 
(6.13 to 14.58)
−2.43 (0.286) 1058 26.94 
(23.38 to 30.50)
−8.28 (<0.001) 16.05 (<0.001) −5.85 (0.057)
ORA 4374 12.79 
(11.33 to 14.24)
5255 35.22 
(33.28 to 37.16)
21.89 (<0.001)
Attended by a 
skilled health 
worker (births last 
5 years)†
K/SK 451 38.74 
(29.48 to 47.99)
4.37 (0.369) 1496 64.48 
(60.39 to 68.56)
−3.07 (0.180) 23.68 (<0.001) −7.44 (0.167)
ORA 7036 34.37 
(32.03 to 36.71)
7588 67.55 
(65.66 to 69.45)
31.12 (<0.001)
Caesarean birth
(births last 
5 years)†
K/SK 451 2.29
(−0.11 to 4.69)
0.11 (0.932) 1496 5.09 
(3.74 to 6.44)
−0.94 (0.227) 2.33 (0.098) −1.04 (0.477)
ORA 7036 2.19 
(1.74 to 2.64)
7588 6.03 
(5.31 to 6.75)
3.37 (<0.001)
Postnatal care 
within 24 hours
(last birth last 
2 years)†
K/SK 169 2.09 
(−0.18 to 4.36)
−0.63 (0.612) 523 17.17 
(13.28 to 21.06)
0.11 (0.958) 14.74 (<0.001) 0.74 (0.767)
ORA 2811 2.72 
(1.86 to 3.58)
2680 17.06 
(15.30 to 18.81)
14.00 (<0.001)
Unmet need for 
contraception 
(married women)†
K/SK 283 37.14 
(30.39 to 43.88)
−1.38 (0.696) 1133 21.49 
(18.55 to 24.44)
2.21 (0.177) −14.65 (<0.001) 3.59 (0.357)
ORA 4484 38.52 
(36.90 to 40.13)
5619 19.28 
(18.00 to 20.57)
−18.24 (<0.001)
Continued
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Importantly, under-five mortality dropped precipi-
tously in both groups during the study period from 229.8 
to 83.2 under-five deaths per 1000 live births in Kire-
he/S. Kayonza (P<0.001) and from 157.7 to 75.8 in ORAs 
(P<0.001) (table 3, column H). These changes repre-
sent annual reductions in under-five mortality of 12.8% 
and 8.9% for the intervention and ORAs, respectively 
(table 3, column I). The greatest reductions in child-
hood mortality occurred among the poorest households 
in Kirehe/S. Kayonza with a dramatic drop in mortality 
from 275.4 to 89.4 deaths per 1000 live births in Kirehe/S. 
Kayonza (annual rate of reduction: 13.5%) compared 
with 152.2 to 76.2 deaths per 1000 live births in ORAs 
(annual rate of reduction: 9.0%). Figure 2 shows that 
the gains in child survival in wealthier strata were much 
less steep. By 2010, there were no significant differences 
between Kirehe/S. Kayonza and ORAs in terms of child 
health outcomes (P>0.05 for all) (table 3, column G).
In 2005, the standardised male adult mortality rate was 
lower in Kirehe/S. Kayonza than in ORAs (P=0.016), and 
there was no difference in rates for women (P=0.233) 
(table 3, column D). Both female and male adult mortality 
in Kirehe/S. Kayonza dropped between 2005 and 2010 
(from 497 to 257 deaths per 100000 among women and 
from 400 to 326 deaths per 100000 among men) (table 3, 
columns C and F), and there was no difference in the 
change in standardised adult mortality rates between the 
two groups (P=0.062) (table 3, column J).
dIsCussIon
Between 2005 and 2010, coverage of health system 
outputs improved dramatically in the area of south-
east Rwanda targeted by the intervention and in ORAs 
of the country. This increased coverage was accompa-
nied by steep declines in adult, under-five, infant and 
neonatal mortality in both settings. Although changes 
in health system outputs were similar in both groups, 
the average annual declines in under-five, infant and 
neonatal mortality were steeper in the intervention area. 
The differences in these rates of decline in population 
outcomes did not meet statistical significance, however, 
possibly because the 2005 RDHS was underpowered to 
detect subregional differences, and we did not over-
sample the intervention area at baseline.
These data are consistent with the findings from a 
recent overview of global trends in child mortality that 
identified Rwanda as a top performer worldwide in 
reducing under-five mortality between 2000 and 2015.22 
Though Rwanda is classified as a least developed country, 
its national 9.9% annual rate of reduction in under-
five deaths is surpassed only by the upper middle-in-
come nation of the Maldives.23 This reduction is more 
than twice the global rate of 4.4% during the same time 
period.23
Multiple studies in other settings suggest that national 
health gains can often mask substantial heterogeneity 
in health system performance and outcomes.24 25 In 
many settings, impoverished and/or geographically 
inaccessible areas have experienced slower progress in 
achieving health goals.26 27 In other studies, socioeco-
nomic status did not correlate well with health system 
performance.28 Our results show that the historically 
unprecedented improvement in health indicators not 
only extends to urban and wealthier areas of the country, 
but is also possible among its poorest and most geograph-
ically isolated residents. Notably, almost all of the decline 
in under-five mortality occurred among the lowest two 
wealth quintiles in the Kirehe/S. Kayonza region where 
the intervention included specific components (subsidies 
of insurance premiums and copays, nutrition support and 
compensated village-based community health workers) 
designed to address inequities in access to care.
How were the remarkable improvements in health 
outcomes made in the regions and socioeconomic 
groups we assessed? Several previous reports describe 
the major components of Rwanda’s national health 
strategy during this period of success.22 29 Like Rwan-
da’s plan to improve health outcomes throughout the 
country, our intervention was deliberately comprehen-
sive, and it is challenging to disentangle specific compo-
nents that contributed to the health gains observed. 
Interestingly, despite the fact that under-five mortality 
Indicator 
(subpopulation)
A
2005 2010 Trends
Comparison of 
trends
B C D E F G H I
Region N % (95% CI)
K/SK versus 
ORA (P values) N % (95% CI)
K/SK versus 
ORA (P values)
2005 versus 2010 
(P values)
2005–2010 K/SK 
versus ORA (P 
values)
Current use 
of modern 
contraceptive 
(married women)†
K/SK 283 13.85 
(9.63 to 18.07)
5.61 (0.011) 1133 46.15 
(42.45 to 49.85)
1.36 (0.515) 29.67 (<0.001) −4.25 (0.162)
ORA 4484 8.24 
(7.28 to 9.20)
5619 44.79 
(43.00 to 46.57)
33.92 (<0.001)
Modified 
composite 
coverage index
K/SK – 57.9 – – 75.0 – – – 
ORA – 58.7 – 73.8 – 
†Adjusting for mother’s/woman’s age and household wealth.
ARI, acute respiratory infection; ORT, oral rehydration therapy.
Table 2 Continued 
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was almost one-third lower in ORAs than it was in Kire-
he/S. Kayonza in 2005, the modified CCI of the set of 
interventions thought to reduce under-five mortality was 
very similar between the groups. Nonetheless, Kirehe/S. 
Kayonza initially trailed the ORAs in two interventions 
most likely to target common causes of death among chil-
dren in lower-income and middle-income countries: case 
management of pneumonia and diarrhoea. Importantly, 
Table 3 Health outcomes 2005–2010 in Kirehe/S. Kayonza (K/SK) and other rural areas (ORAs), adjusting for mother’s age 
and household wealth
Indicator 
(subpopulation)
A
2005 2010 Trends
Comparison of 
trends
B C D E F G H I J
Region N % (95% CI)
K/SK versus 
ORA (P 
values) N % (95% CI)
K/SK 
versus ORA 
(P values)
2005 versus 
2010 (P 
values)
Average 
annual 
rate of 
reduction
2005–2010 K/SK 
versus ORA (P 
values)
Children
ARI in last 
2 weeks
(<5 years)†
K/SK 365
27.24 
(19.71 to 34.77)
10.99 (0.005)
1402
8.41 
(6.54 to 10.28)
−1.64 (0.125)
−18.64 
(<0.001)
n/a
−12.63 (0.002)ORA 6288
16.25 
(14.75 to 17.75) 7152
10.05 
(9.10 to 11.00)
−6.01 
(<0.001)
n/a
Diarrhoea in last 
2 weeks
(<5 years)†
K/SK 365
19.51 
(14.52 to 24.49)
5.41 (0.038)
1402
12.18 
(10.13 to 14.23)
−0.81 (0.490)
−7.24 
(0.009)
n/a
−6.22 (0.030)ORA 6288
14.10 
(12.98 to 15.23) 7152
12.99 
(11.93 to 14.06)
−1.02 
(0.202)
n/a
Fever in last 
2 weeks
(<5 years)†
K/SK 365
37.67 
(29.90 to 45.43)
11.91 (0.003)
1402
15.41 
(12.71 to 18.10)
−0.52 (0.729)
−22.17 
(<0.001)
n/a
−12.43 (0.004)ORA 6288
25.75 
(23.91 to 27.59) 7152
15.92 
(14.76 to 17.08)
−9.74 
(<0.001)
n/a
Stunting 
(<–2SD)
(<5 years)†
K/SK 184
47.85 
(43.87 to 51.83)
−5.43 (0.018)
204
46.83 
(41.19 to 52.47)
0.51 (0.868)
3.64 (0.314)
n/a
5.94 (0.122)ORA 3158
53.28 
(51.17 to 55.39) 3636
46.32 
(44.20 to 48.44)
−2.30 
(0.163)
n/a
Wasting (<–2SD)
(<5 years)†
K/SK 184
3.22 
(0.28 to 6.16)
−1.61 (0.307)
204
2.14 
(0.39 to 3.89)
−0.63 (0.503)
−0.45 
(0.800)
n/a
0.97 (0.596)ORA 3158
4.82 
(3.90 to 5.75) 3636
2.77 
(2.16 to 3.39)
−1.42 
(0.018)
n/a
Under-five 
mortality rate 
(per 1000 live 
births)
K/SK 310
229.8 
(158.8 to 300.7)
72.1 (0.045)
1347
83.2 
(66.2 to 100.2)
7.4 (0.418)
−146.6 
(<0.001)
−12.8
−64.7 (0.081)ORA 5116
157.7 
(145.8 to 169.5) 6575
75.8 
(69.1 to 82.5)
−81.9 
(<0.001)
−8.9
Infant mortality 
rate (per 1000 
live births)
K/SK 422
129.6 
(77.8 to 181.3)
41.3 (0.116)
1462
49.4 
(35.0 to 63.9)
0.5 (0.948)
−80.2 
(0.003)
−19.3
−40.8 (0.136)ORA 6528
88.3 
(79.4 to 97.2) 7403
48.9 
(43.3 to 54.5)
−39.4 
(<0.001)
−11.8
Neonatal 
mortality rate 
(per 1000 live 
births)
K/SK 452
55.9 
(29.9 to 81.9)
17.6 (0.185)
1524
26.2 
(15.4 to 36.9)
−0.9 (0.875)
−29.7 
(0.035)
−15.2
−18.5 (0.201)ORA 7012
38.3 
(32.9 to 43.8) 7662
27.1 
(23.0 to 31.2)
−11.2 
(0.001)
−6.9
Adults
Mortality 
among women 
(per 100 000 
population)
Observed 3952
497.4 
(256.4 to 738.5)
−151.8 (0.233)
18 279
256.8 
(178.3 to 335.3)
−72.3 (0.110)
−240.6 
(0.063)
−13.2
79.5 (0.556)Expected* 74 932
649.2 
(584.1 to 714.4) 96 696
329.1 
(288.1 to 370.1)
−320.1 
(<0.001)
−13.6
Mortality 
among men 
(per 100 000 
population)
Observed 4059
400.0 
(171.2 to 628.9)
−296.0 (0.016)
16 707
325.7 
(236.8 to 414.6)
−21.4 (0.673)
−74.3 
(0.553)
−4.1
274.6 (0.039)Expected* 66 592
696.0 
(621.3 to 770.7) 90 199
347.1 
(303.2 to 390.9)
−348.9 
(<0.001)
−13.9
Total adult 
mortality 
(per 100 000 
population)
Observed 8011
445.0 
(279.4 to 610.7)
−226.2 (0.011)
34 986
289.0 
(230.0 to 348.0)
−48.8 (0.158)
−156.0 
(0.082)
−8.6
177.4 (0.062)Expected* 141 524
671.2 
(618.5 to 724.0) 186 894
337.8 
(304.7 to 370.8)
−333.5 
(<0.001)
−13.7
*Expected represents mortality rates in other rural areas standardised to the age distributions in Kirehe/S. Kayonza.
†Adjusting for mother’s age and household wealth.
ARI, acute respiratory infection.
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these indicators capture access to curative care rather 
than preventive measures and may be better proxies for 
existence of health systems than are interventions such 
as vaccination or vitamin A supplementation, which can 
be delivered without investment in the kinds of health 
system building blocks that were targeted in Kirehe/S. 
Kayonza. The modified CCI increased similarly in both 
groups, but Kirehe/S. Kayonza had closed the gap in 
case management for diarrhoea and achieved higher 
coverage for exclusive breast feeding and case manage-
ment of ARI by 2010. In contrast, ORAs outperformed 
Kirehe/S. Kayonza in measles vaccination, vitamin A 
supplementation, ANC4 and skilled birth attendants, all 
of which might be expected to have a less direct impact 
on overall mortality.
In addition to a focus on equity, the construction or 
renovation of two district hospitals, and higher coverage 
of horizontal interventions addressing major causes 
of child death, the Kirehe/S. Kayonza intervention 
combined a rigorous programme of compensated village-
based community health workers with improvements 
in infrastructure and staffing of the facilities to which 
community health workers referred patients for care. The 
indicators of healthcare coverage assess the frequency, 
but not the quality, of the care provided, and are there-
fore coarse tools by which to measure the impact of 
the range of interventions embodied in the six WHO 
building blocks. For example, treatment of malaria with 
an antipyretic rather than artemesin meets the criteria 
for case management of fever as assessed in the DHS 
but is unlikely to have a major impact on child mortality. 
Recognising the challenges of designing an evaluation 
that captures the relative effects of these components of 
our care model, we suggest that the impact of the Kire-
he/S. Kayonza intervention is partly attributable to the 
coordinated strengthening of services at multiple levels 
(community, health centres and hospitals) with a focus 
on quality of care.30
We note several important limitations to this study. 
First, mother-reports may be imperfect measures of illness 
and treatment, especially for such indicators as ARIs 
including pneumonia and whether the child received 
antibiotic treatment.31 Second, the sample size at base-
line was small. Dwyer-Lindgren and colleagues have 
shown that under-five mortality estimates derived from 
birth histories with sample sizes under 500 can be biased 
Figure 2 Comparison of trends in under-five, infant and neonatal mortality between 2005 and 2010 in Kirehe/S. Kayonza 
versus other rural areas by household wealth status.
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and usually underestimate the true value of mortality.32 
They also show that underestimation of mortality tends 
to occur when estimates are based on surveys conducted 
in high mortality settings. With a sample size of only 359 
birth records in the 2005 survey of the very high mortality 
intervention region, it is possible that the true Kirehe/S. 
Kayonza baseline under-five mortality rate was even 
higher and the decline between 2005 and 2010 steeper 
than we estimated.
Third, the cross-sectional nature of the surveys did not 
allow for tracking changes in individuals, households 
or communities. Anecdotal evidence suggests that a 
number of chronically sick individuals and their families 
from nearby districts moved to Kirehe/S. Kayonza after 
health system improvements began. The opening of new 
health facilities and establishment of the PIH-Rwanda 
headquarters in Kirehe/S. Kayonza also attracted new, 
better educated employees to the region and stimulated 
related commerce. The cross-sectional study design does 
not allow for determining to what extent changes in 
health were driven by the health system strengthening 
intervention in the baseline population, compared with 
other demographic changes in the population that 
occurred during the intervention period. Fourth, we 
were only able to measure WHO building block indi-
cators available in the RDHS questionnaire; data about 
perception or quality of care, for example, could not be 
included. As in any household questionnaire, selection 
and recall biases may have also affected estimates.
Finally, the ideal evaluation of this intervention would 
have involved comparing the 2010 indicators in the inter-
vention group to a population that had identical 2005 
health status but which had not received the intervention. 
As discussed in the Methods section, the intervention site 
was chosen because it had the highest under-five mortality 
in the country, and we were thus unable to identify an 
area with a similarly high rate of under-five mortality. 
If improvements in child mortality rates are easier to 
achieve when the baseline levels are high, our finding of 
a steeper decline in mortality in the intervention group 
may simply reflect this discrepancy in the baseline rate, 
rather than any meaningful difference between the inter-
vention and ORAs. However, we find little evidence in the 
literature to support this ‘low hanging fruit’ hypothesis 
with most repeated measurements of mortality over time 
in a specific population demonstrating a linear decline 
on a log scale.33
ConClusIon
Rwanda experienced historic health improvements 
between 2005 and 2010, and those improvements were 
even more pronounced in Kirehe/S. Kayonza where 
RMOH-PIH rolled out an integrated health system 
strengthening intervention in 2005. This area had 
substantially poorer performance on population health 
outcomes in 2005 but narrowed that gap considerably 
by 2010. Furthermore, the drop in under-five mortality 
in Kirehe/S. Kayonza was modestly higher than that 
of the historic drop experienced nationally and in 
ORAs. Although we are not able to attribute health 
improvements in Kirehe/S. Kayonza to the RMOH-PIH 
programme alone, the RMOH-PIH programme likely 
played a key role in these monumental health achieve-
ments.
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